Sjögren’s Syndrome News

Recently published results showed salivary gland ultrasonography reliably assessed parenchymal inhomogeneity by multiple assessors among patients with established primary Sjögren’s syndrome.

Patients with rheumatoid arthritis and secondary Sjögren’s syndrome may benefit from abatacept, which may be effective in treating symptoms of both conditions, according to recently published research.

Researchers of this study found the autoantibody poly(U)-binding-splicing factor 60 kDa presents distinctly in patients with Sjögren’s syndrome and dermatomyositis.

Patients with cancer treated with ipilimumab or nivolumab alone or in combination with each other experienced a higher than normal risk of developing autoimmune joint and tissue diseases, according to results recently published in Annals of Rheumatic Diseases.

Hand osteoarthritis was more frequently associated with patients who had primary Sjögren syndrome compared with patients who had systemic lupus erythematosus, according to results.

Recently published results showed transforming growth factor-beta signaling may be suppressed collectively by Sjögren’s syndrome-associated micro ribonucleic acid as opposed to pro-inflammatory interleukin-12 and toll-like receptor/nuclear factor-kappa beta pathways in Sjögren’s syndrome pathogenesis.

NEW YORK CITY — Diane R. Mould, PhD, president of Projections Research Inc. discussed pharmacodynamics in the use of biologic therapies in rheumatic, gastroenterological and dermatologic diseases here at the Interdisciplinary Autoimmune Summit.

NEW YORK CITY — Stephen I. Katz, MD, PhD, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the NIH, presented the keynote speech at the Interdisciplinary Autoimmune Summit and urged rheumatologists, dermatologists, gastroenterologists and other health care professionals who treat patients with autoimmune diseases to work together. He also discussed the future work of NIH research into autoimmune diseases from a multidisciplinary approach.

The presence of rheumatoid factor and level of disease activity may be risk factors for the development of lymphoma in patients with primary Sjögren’s syndrome, according to recently published research.

The most highly read articles on Healio.com/Rheumatology about recently published research into Sjögren’s syndrome focus on symptoms, such as pruritus, and patient subtypes related to disease activity. Techniques to identify patients at risk for high disease activity also were highlighted.